Navigation Links
Bypass Surgery, Drug-eluting Stents Possess Similar Risk and Outcome

Drug-eluting stent therapy and bypass surgery for coronary artery disease have about the same risk for a major cardiac event within 30 days after the procedures// , according to researchers.

The two also have similar outcomes three years after treatment. Patients with coronary arteries narrowed by atherosclerosis are often candidates for either bypass surgery to reroute the arteries' blood flow or a stent, which is a small mesh tube that helps keep arteries open after angioplasty, a procedure to open clogged arteries.

Previous studies have found that placing bare-metal stents is safer than bypass surgery. However, "bypass surgery is much more successful for restoring patients' blood flow in the long-term because arteries with traditional stents re-narrow in about one out of every three cases," said James M. Wilson, M.D., senior author of the study. The newer drug-eluting stents were developed to help keep arteries open longer, but until now their effectiveness had not been compared with the gold standard bypass surgery.

Wilson and colleagues analyzed 799 drug-eluting stent patients and 799 coronary bypass patients, comparing how they fared in the first 30 days after their procedures and during the next three years.

"What we found came as a bit of a surprise," said Wilson, program director of the Cardiology Fellowship Program at St. Luke's Episcopal Hospital and Texas Heart Institute in Houston. "We found that the likelihood of any complication in the hospital was the same whether you had a drug-eluting stent or bypass. Five percent of drug-eluting stent patients had some major complication in the hospital, mostly heart attack, as opposed to about 3.8 percent of the patients who had bypass. Those numbers, although seemingly different, are statistically the same."

"We have done further research since comparing drug-eluting to bare-metal stents and have found that the higher complication rate among drug-e luting patients is not due to the technology but rather patient selection," said Wilson, who is also assistant chief of cardiology at St. Luke's Episcopal Hospital. "Now that we have more confidence in the long-term effectiveness of the drug-eluting stents, we are using the technology on much sicker patients."

Drug-eluting stents were better than bare-metal stents when compared to bypass surgery in terms of survival, with no statistically significant difference between the drug-eluting stents and bypass groups. Researchers reported that the death rate at three years with bypass was 6.6 percent and 9 percent after drug-eluting stent therapy.

The research suggests that if doctors use drug-eluting stents in patients who are lower risk, they might expect even more favorable results, said Muhammad S. Munir, M.D., lead author of the study and a nonclinical research fellow at the Texas Heart Institute.

"If the patient selection is made less aggressively or more optimally, it may give drug-eluting stents better results in the long run, making drug-eluting stents emerge as a treatment that would be better than all other contemporary methods," Munir said.

Wilson said it's best, "sticking to what we do well. We have reported that the risk of bypass surgery and drug-eluting stents is the same among high-risk patients. So, if we choose the patients we know we can treat well with stents, then it is reasonable to treat them by a catheter rather than by surgery. If we can't do a good job with stents, then bypass is the better choice."

Source-Eurekalert
'"/>




Related medicine news :

1. Bypass Heart Surgery Performed Without General Anesthesia
2. Older Men Surviving Coronary Bypasses
3. Bypass Surgery & Pleural Effusion
4. Life after Bypass not so Promising for Women.
5. The Reason For Loss Of Appetite After Gastric Bypass
6. Bypassing open heart bypass surgery...
7. Surgeons Perform Robotic Gastric Bypass Surgery
8. Poor Andhra Women Enable Bypass Surgery Paying 50 Paise Each
9. Prayers Do Not Help Healing Process In Bypass Patients
10. Gastric Bypass And Laparoscopic Reflux Surgery Gaining Popularity
11. For Super-Obese Patients, Duodenal Switch Beats Gastric Bypass
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... , ... October 13, 2017 , ... The Visiting Nurse ... Market. Featuring a collection of specialty vendors and unique items from across the nation, ... quality-focused health and wellness services offered by the VNA. The boutique will be ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... Yisrayl Hawkins, ... week that explains one of the most popular and least understood books in the ... cryptic and puzzling descriptions that have baffled scholars for centuries. Many have tossed it ...
(Date:10/13/2017)... ... ... Journey: From the Mountains to the Mission Field”: the story of a missionary couple ... From the Mountains to the Mission Field” is the creation of published author, Carole ... and currently teaches a class of ladies at her church, which she has taught ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... sleep apnea using cutting-edge Oventus O2Vent technology. As many as 18 ... characterized by frequent cessation in breathing. Oral appliances can offer significant relief to ...
(Date:10/12/2017)... ... October 12, 2017 , ... IsoComforter, Inc. ( https://isocomforter.com ... the introduction of an innovative new design of the shoulder pad. The shoulder ... maximum comfort while controlling your pain while using cold therapy. By utilizing ice and ...
Breaking Medicine News(10 mins):
(Date:10/10/2017)... Pa. , Oct. 10, 2017   West ... in innovative solutions for injectable drug administration, today shared ... West,s ID Adapter for improving the intradermal administration of ... Fourth Skin Vaccination Summit in May 2017 by Dr. ... Lead, Polio Department, World Health Organization (WHO), and recently ...
(Date:10/4/2017)... Oct. 4, 2017  According to the Centers for Disease Control and ... October . PhysicianOne Urgent Care is helping communities across Massachusetts ... , by offering no-cost* flu shots through the end of the ... certain health insurance regulations. ... time to get a flu shot is by the end of October, ...
(Date:10/2/2017)... 2, 2017  AllianceRx Walgreens Prime, the combined central ... and pharmacy benefit manager Prime Therapeutics LLC (Prime), today ... included the unveiling of new signage at its headquarters ... as at a few other company-owned facilities across the ... patients, some of whom will begin to see the ...
Breaking Medicine Technology: